Peptide Synthesis Market – Global Industry Analysis and Forecast (2024-2030)

Peptide Synthesis Market size was valued at USD 596.66 Million in 2023 and the total Peptide Synthesis Market revenue is expected to grow at a CAGR of 7.5% from 2024 to 2030, reaching nearly USD 596.66 Million by 2030.

Peptide Synthesis Market Overview:

Peptides are highly effective and selective signaling molecules that bind to particular cell surface receptors, such as ion channels or G protein-coupled receptors (GPCRs), where they cause intracellular reactions. Peptides are a good starting point for the creation of new therapies due to their excellent pharmacological profile and intrinsic characteristics. They are known to have outstanding safety, tolerability, and effectiveness characteristics in humans as a result of their specificity. Peptide therapeutics have lower processing complexity than protein-based biopharmaceuticals, which translates to lower production costs that are more similar to those of small molecules.Peptide Synthesis Market SnapshotTo know about the Research Methodology :- Request Free Sample Report

Peptide Synthesis Market Dynamics:

In addition to the conventional peptide design, a number of new peptide technologies have emerged, representing growth opportunities for market players and the potential for further development of the peptide synthesis market. Among these are peptides with many functions and the ability to penetrate cells, peptide drug conjugates, and inventions based on novel administration methods. Over the past ten years, peptides have been used for a wider range of purposes, including therapeutic peptide science and biotechnology. The market for peptide synthesis is the greatest benefit to a rise in the use of peptides for commercial reasons. For instance, Lupron, a peptide-based medication made by AbbVie that is used to treat illnesses including prostate cancer and others, had all sales of more than USD 755 million in 2020. Important pharmaceutical, biotechnology, and peptide synthesis market participants have increased their R&d expenditure in response to the COVID-19 epidemic. Peptide synthesis has gained attention due to the increased demand for vaccinations and peptide-based medicines. The peptide-based strategy marks a turning point because peptides have proven to have distinctive characteristics of selectivity and specificity toward particular targets. A peptide-based vaccination candidate called CoVac-1 is made up of SARS-CoV-2 T-cell epitopes derived from several viral proteins, along with the Toll-like receptor 1/2 agonist XS15 emulsified in Montanide ISA51 VG, with the goal of inducing strong SARS-CoV-2 T-cell immunity to fight off COVID-19. These developments have increased the need for materials and machinery for the manufacture of peptides. Market Drive- Increasing use of peptide in the pharmaceutical sector Peptides are extremely potent and targeted pharmacological ingredients. They are used in a wide variety of therapeutic areas because of the diversity of their biological actions. Due to their broad chemical space, high biological activity, high specificity, the relative simplicity of synthesis, ready availability, and low toxicity, peptides are increasingly being considered as potential active medicinal components. Peptides bring in billions of dollars in three important therapeutic areas: oncology, diabetes, and obesity. The need for peptides is also rising for the treatment of renal failure, uncommon disorders, and cardiovascular and neurological illnesses. There are currently more than 100 peptide-based medications available. With almost 700 peptide medicines and therapeutic peptides now undergoing preclinical development, this figure is forecast to significantly increase. Market Opportunity- Development of Personalized medicine The concept of individualized therapy with the best response and largest safety margin to ensure improved patient care has sparked interest in personalized treatment. Proteomic analysis is an attractive and effective method for identifying the molecular profiles of distinct tissues, whether they are healthy or afflicted. The next significant advancement in customized medicine is personalized proteomics or proteomic profiling, which sheds new light on disease patho mechanisms. As part of the EU-funded ElectroMed project, researchers suggested creating a user-friendly platform to program electrochemically guided peptide synthesis based on a microfluidic multiplexing system that is managed by software in order to increase the use of proteomics in personalized medicine. Then, label-free sensors based on nanomaterials will be used to identify and quantify the ligand-receptor complexes. The technology will make it possible to apply proteomics for personalized treatment by enabling the automated injection of the various reagents required for the ligand synthesis for the personalized and controlled synthesis of peptides. Growing investments in personalized medicine can be primarily due to the increased prevalence of diseases like cancer and cardiovascular disease (CVD) and the growing demand for reducing treatments with few adverse effects. Personalized medicine has the potential to raise healthcare quality while also cutting costs. Players in the peptide synthesis market will have growth potential as a result of such advancements in the area of customized medicine. Market Challenges- Issue associated with the route of administration of peptide drug Due to insufficient absorption from the gastrointestinal tract, the bulk of therapeutic peptides is supplied parenterally. The use of regular injections during long-term treatment has serious disadvantages, and peptide medicines are typically advised for chronic illnesses. The oral route of medication administration offers benefits including self-administration with a high degree of patient acceptability and compliance in contrast to this difficult and sometimes dangerous mode of drug delivery. Pre-systemic enzymatic breakdown and inadequate penetration of the intestinal mucosa are the main causes of the limited oral bioavailability of peptide drugs. Additionally, the molecular weight, lipophilicity, and charged functional groups of these medicines are often high, which hinders absorption. These properties cause the majority of orally given peptides to have low bioavailability and brief half-lives. The problem of absorption is solved by intravenous or subcutaneous delivery of these therapeutics, but other factors, such as systemic proteases, rapid metabolism, opsonization, conformational changes, dissociation of subunit proteins, non-covalent complexation with blood products, and destruction of labile side-groups, limit the bioavailability of peptide and protein therapeutics. Peptide-based medications are within the category of biologics, both small and large molecules. Peptides have created a number of regulatory issues due to their position on the threshold between usual tiny chemicals and large proteins. The majority of these medications are produced chemically. Although diverse peptide medications have a similar production method, they all have quite different action mechanisms. Therefore, it is a difficult challenge to create a uniform set of regulatory rules that can effectively address the safety and quality requirements for such a diverse group of molecular entities with various special modes of action. There are no official regulatory agency guidelines for creating this class of treatments. Additionally, there is a conflict on the regulatory approval of peptide-based medicines between the European Medicines Agency (EMA) and the Food and Drug Administration (FDA). The FDA's Center for Drug Evaluation and Research (CDER) is responsible for peptide drug evaluation, however, the European Medicines Agency (EMA) prefers a centralized process to the mutual recognition system (the marketing of peptide-based drugs is allowed throughout the European Union under the centralized procedure). Therapeutic peptides are finding it difficult to obtain permits due to the intermittent nature of the laws, which in turn is limiting their potential uses. This is regarded as a significant barrier to the market for peptide synthesis growth.

Peptide Synthesis Market Segment Analysis:

Based on the Technology, The market is divided into three categories based on technology: hybrid technology, liquid phase peptide synthesis (LPPS), and solid-phase peptide synthesis (SPPS). Throughout the forecast period, liquid-phase peptide synthesis has dominated the market, while solid-phase peptide synthesis has shown the highest increase between 2024 and 2030. The expenses involved with peptide synthesis have been significantly decreased due to advancements and the incorporation of automation in both liquid and solid-phase synthesis. This is forecast to accelerate the adoption of peptide synthesis around the world, increasing the amount of revenue generated country over the course of the forecast period. SPPS is a good method for developing API processes and GMP manufacturing processes since it can produce lengthy peptide sequences (more than 10 amino acids) at a low cost in smaller numbers. However, when using SPPS, the costs of purification have a tendency to increase the price of manufacturing at any desired level of output.Peptide Synthesis Market Size Application Based on the Application, The peptide synthesis market is divided into medicines, diagnosis, and research. Revenue from the therapeutics segment covers a range of conditions, including cancer, metabolic, cardiovascular, respiratory, gastrointestinal (GI) disorders, infectious illnesses, pain, dermatological, CNS, and renal. The market for peptide synthesis applications has been dominated by the therapeutics sector since 2023, and this trend is forecast to continue over the coming years. However, from 2024 to 2030, the diagnosis category is forecast to grow at the quickest rate. Due to the widespread use of synthetic peptides in the treatment of cancer, this market has become a significant source of revenue for the therapeutics sector. Additionally, the segment for metabolic disorders is forecast to boost at the quickest rate over the course of the forecast period, and this increase can be due to the pipeline's strength and the abundance of peptide candidates for the treatment of type II diabetes. It is expected that recently identified peptides important for metabolic regulation may provide helpful information for developing efficient treatment strategies. Based on the End-Use, the peptide synthesis market is divided into three segments that are pharmaceutical and biotechnology firms, contract development and manufacturing firms (CROs/CMOs), and academic and research institutions. A key factor in the dominance of pharmaceutical and biotechnology businesses' end-use sector in the market is the industry's robust rise in peptide therapies. While the CRO and CMO segments experienced the most growth between 2024 and 2030.

Regional Insights:

North America held the biggest market share for peptide synthesis in 2023, accounting for Xx% of total market revenue. Europe and the Asia Pacific region came in second and third, respectively, with shares of XX% and XX%. The high prevalence of chronic diseases, rising investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, and rising focus on the creation of personalized therapeutics are all factors that contribute to North America's significant market share in the world. The significant US market share is primarily explained by the country's growing life science research activities as well as the rising incidence of chronic illnesses like cancer. The objective of the report is to present a comprehensive analysis of the global Peptide Synthesis Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Peptide Synthesis Market dynamic, structure by analyzing the market segments and projecting the Peptide Synthesis Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Peptide Synthesis Market make the report investor’s guide.

Peptide Synthesis Industry EcosystemPeptide Synthesis Industry EcosystemPeptide Synthesis Market Scope: Inquire before buying

Global Peptide Synthesis Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: USD 596.66 Mn
Forecast Period 2024 to 2030 CAGR: 7.5% Market Size in 2030: USD 989.89 Mn
Segments Covered: by Product Equipment Reagents & Consumables Others
by Technology Solid Phase Peptide Synthesis Liquid Phase Peptide Synthesis Hybrid Technology
by Application Therapeutics Diagnosis Research
by End Users Pharmaceutical & Biotechnology Companies Contract Development & Manufacturing Organization Academic & Research Institutes

by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Peptide Synthesis Market Key Players

1. Bachem Holdings 2. Thermo Fisher Scientific 3. Merck KGgA 4. GenScript Biotech Corporation 5. Kaneka Corporation 6. Biotage AG 7. Syngen International Ltd 8. Mesa Laboratories 9. CEM Corporation 10. ProteoGenix 11. Bio-Synthesis 12. Purolite 13. ChemPep 14. AmbioPharm 15. CPC Scientific Inc. 16. Polypeptide 17. Lonza Group Ltd 18. USV Peptides

Frequently Asked Questions:

1. What segments are covered in the Global Peptide Synthesis Market report? Ans. The segments covered in the Peptide Synthesis Market report are based on Product, Technology, Application, and End User. 2. Which region is expected to hold the highest share in the Global Peptide Synthesis Market? Ans. The North America region is expected to hold the highest share of the Peptide Synthesis Market. 3. What is the market size of the Global Peptide Synthesis Market by 2030? Ans. The market size of the Peptide Synthesis Market by 2030 is expected to reach USD 989.89 Mn. 4. What is the forecast period for the Global Peptide Synthesis Market? Ans. The forecast period for the Peptide Synthesis Market is 2024-2030. 5. What was the Global Peptide Synthesis Market size in 2023? Ans. The Global Peptide Synthesis Market size was USD 596.66 Million in 2023.
1. Peptide Synthesis Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Peptide Synthesis Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.4.1. Main suppliers and their market positioning 2.4.2. Key customers and adoption rates across different sectors 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Product Segment 2.5.3. End-user Segment 2.5.4. Revenue (2023) 2.5.5. Geographic distribution of major customers 2.6. Market Structure 2.6.1. Market Leaders 2.6.2. Market Followers 2.6.3. Emerging Players 2.7. Mergers and Acquisitions Details 3. Market Size Estimation Methodology 3.1.1. Bottom-Up Approach 3.1.2. Top-Down Approach 4. Market Dynamics 4.1. Peptide Synthesis Market Trends 4.2. Peptide Synthesis Market Dynamics 4.2.1.1. Drivers 4.2.1.2. Restraints 4.2.1.3. Opportunities 4.2.1.4. Challenges 4.3. PORTER’s Five Forces Analysis 4.3.1. Threat of New Entrants 4.3.2. Threat of Substitutes 4.3.3. Bargaining Power of Suppliers 4.3.4. Bargaining Power of Buyers 4.3.5. Intensity of Competitive Rivalry 4.4. PESTLE Analysis 4.5. Regulatory Landscape By Region 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. South America 4.5.5. MEA 4.6. Analysis of Government Schemes and Initiatives For the Peptide Synthesis Industry 4.7. Supply Chain Analysis 4.8. Pricing Analysis 4.9. Peptide Synthesis Industry Ecosystem 4.9.1. Key Players in the Peptide Synthesis Industry Ecosystem 4.9.2. Role of Companies in the Peptide Synthesis Industry Ecosystem 4.10. Patent Analysis 4.10.1. Key Companies with the Highest Number of Patents 4.10.2. Patent Registration Analysis 4.10.3. Number of Patents Granted Still 2024 4.11. Technology Analysis 4.12. Investment and Funding Scenario 4.12.1. Major Investment and Funding 5. Peptide Synthesis Market: Global Market Size and Forecast By Segmentation (By Value USD Mn) (2023-2030) 5.1. Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 5.1.1. Equipment 5.1.2. Reagents & Consumables 5.1.3. Services 5.2. Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 5.2.1. Solid Phase Peptide Synthesis 5.2.2. Liquid Phase Peptide Synthesis 5.2.3. Hybrid Technology 5.3. Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 5.3.1. Therapeutics 5.3.2. Diagnosis 5.3.3. Research 5.4. Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 5.4.1. Pharmaceutical & Biotechnology Companies 5.4.2. Contract Development & Manufacturing Organization 5.4.3. Academic & Research Institutes 5.5. Peptide Synthesis Market Size and Forecast, By Region(2023-2030) 5.5.1. North America 5.5.2. Europe 5.5.3. Asia Pacific 5.5.4. South America 5.5.5. MEA 6. North America Peptide Synthesis Market Size and Forecast By Segmentation (By Value USD Mn) (2023-2030) 6.1. North America Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 6.1.1. Equipment 6.1.2. Reagents & Consumables 6.1.3. Services 6.2. North America Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 6.2.1. Solid Phase Peptide Synthesis 6.2.2. Liquid Phase Peptide Synthesis 6.2.3. Hybrid Technology 6.3. North America Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 6.3.1. Therapeutics 6.3.2. Diagnosis 6.3.3. Research 6.4. North America Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 6.4.1. Pharmaceutical & Biotechnology Companies 6.4.2. Contract Development & Manufacturing Organization 6.4.3. Academic & Research Institutes 6.5. North America Peptide Synthesis Market Size and Forecast, By Country (2023-2030) 6.5.1. United States 6.5.1.1. United States Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 6.5.1.1.1. Equipment 6.5.1.1.2. Reagents & Consumables 6.5.1.1.3. Services 6.5.1.2. United States Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 6.5.1.2.1. Solid Phase Peptide Synthesis 6.5.1.2.2. Liquid Phase Peptide Synthesis 6.5.1.2.3. Hybrid Technology 6.5.1.3. United States Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 6.5.1.3.1. Therapeutics 6.5.1.3.2. Diagnosis 6.5.1.3.3. Research 6.5.1.4. United States Peptide Synthesis Market Size and Forecast By End User(2023-2030) 6.5.1.4.1. Pharmaceutical & Biotechnology Companies 6.5.1.4.2. Contract Development & Manufacturing Organization 6.5.1.4.3. Academic & Research Institutes 6.5.2. Canada 6.5.2.1. Canada Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 6.5.2.1.1. Equipment 6.5.2.1.2. Reagents & Consumables 6.5.2.1.3. Services 6.5.2.2. Canada Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 6.5.2.2.1. Solid Phase Peptide Synthesis 6.5.2.2.2. Liquid Phase Peptide Synthesis 6.5.2.2.3. Hybrid Technology 6.5.2.3. Canada Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 6.5.2.3.1. Therapeutics 6.5.2.3.2. Diagnosis 6.5.2.3.3. Research 6.5.2.4. Canada Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 6.5.2.4.1. Pharmaceutical & Biotechnology Companies 6.5.2.4.2. Contract Development & Manufacturing Organization 6.5.2.4.3. Academic & Research Institutes 6.5.3. Mexico 6.5.3.1. Mexico Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 6.5.3.1.1. Equipment 6.5.3.1.2. Reagents & Consumables 6.5.3.1.3. Services 6.5.3.2. Mexico Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 6.5.3.2.1. Solid Phase Peptide Synthesis 6.5.3.2.2. Liquid Phase Peptide Synthesis 6.5.3.2.3. Hybrid Technology 6.5.3.3. Mexico Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 6.5.3.3.1. Therapeutics 6.5.3.3.2. Diagnosis 6.5.3.3.3. Research 6.5.3.4. Mexico Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 6.5.3.4.1. Pharmaceutical & Biotechnology Companies 6.5.3.4.2. Contract Development & Manufacturing Organization 6.5.3.4.3. Academic & Research Institutes 7. Europe Peptide Synthesis Market Size and Forecast By Segmentation (By Value USD Mn) (2023-2030) 7.1. Europe Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 7.2. Europe Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 7.3. Europe Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 7.4. Europe Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 7.5. Europe Peptide Synthesis Market Size and Forecast, By Country (2023-2030) 7.5.1. United Kingdom 7.5.1.1. United Kingdom Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 7.5.1.2. United Kingdom Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 7.5.1.3. United Kingdom Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 7.5.1.4. United Kingdom Peptide Synthesis Market Size and Forecast By End User(2023-2030) 7.5.2. France 7.5.2.1. France Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 7.5.2.2. France Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 7.5.2.3. France Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 7.5.2.4. France Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 7.5.3. Germany 7.5.3.1. Germany Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 7.5.3.2. Germany Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 7.5.3.3. Germany Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 7.5.3.4. Germany Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 7.5.4. Italy 7.5.4.1. Italy Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 7.5.4.2. Italy Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 7.5.4.3. Italy Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 7.5.4.4. Italy Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 7.5.5. Spain 7.5.5.1. Spain Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 7.5.5.2. Spain Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 7.5.5.3. Spain Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 7.5.5.4. Spain Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 7.5.6. Sweden 7.5.6.1. Sweden Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 7.5.6.2. Sweden Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 7.5.6.3. Sweden Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 7.5.6.4. Sweden Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 7.5.7. Austria 7.5.7.1. Austria Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 7.5.7.2. Austria Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 7.5.7.3. Austria Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 7.5.7.4. Austria Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 7.5.8. Rest of Europe 7.5.8.1. Rest of Europe Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 7.5.8.2. Rest of Europe Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 7.5.8.3. Rest of Europe Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 7.5.8.4. Rest of Europe Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 8. Asia Pacific Peptide Synthesis Market Size and Forecast By Segmentation (By Value USD Mn) (2023-2030) 8.1. Asia Pacific Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 8.2. Asia Pacific Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 8.3. Asia Pacific Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 8.4. Asia Pacific Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 8.5. Asia Pacific Peptide Synthesis Market Size and Forecast, By Country (2023-2030) 8.5.1. China 8.5.1.1. China Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 8.5.1.2. China Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 8.5.1.3. China Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 8.5.1.4. China Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 8.5.2. S Korea 8.5.2.1. S Korea Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 8.5.2.2. S Korea Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 8.5.2.3. S Korea Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 8.5.2.4. S Korea Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 8.5.3. Japan 8.5.3.1. Japan Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 8.5.3.2. Japan Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 8.5.3.3. Japan Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 8.5.3.4. Japan Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 8.5.4. India 8.5.4.1. India Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 8.5.4.2. India Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 8.5.4.3. India Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 8.5.4.4. India Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 8.5.5. Australia 8.5.5.1. Australia Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 8.5.5.2. Australia Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 8.5.5.3. Australia Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 8.5.5.4. Australia Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 8.5.6. ASEAN 8.5.6.1. ASEAN Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 8.5.6.2. ASEAN Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 8.5.6.3. ASEAN Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 8.5.6.4. ASEAN Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 8.5.7. Rest of Asia Pacific 8.5.7.1. Rest of Asia Pacific Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 8.5.7.2. Rest of Asia Pacific Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 8.5.7.3. Rest of Asia Pacific Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 8.5.7.4. Rest of Asia Pacific Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 9. South America Peptide Synthesis Market Size and Forecast By Segmentation (By Value USD Mn) (2023-2030) 9.1. South America Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 9.2. South America Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 9.3. South America Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 9.4. South America Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 9.5. South America Peptide Synthesis Market Size and Forecast, By Country (2023-2030) 9.5.1. Brazil 9.5.1.1. Brazil Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 9.5.1.2. Brazil Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 9.5.1.3. Brazil Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 9.5.1.4. Brazil Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 9.5.2. Argentina 9.5.2.1. Argentina Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 9.5.2.2. Argentina Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 9.5.2.3. Argentina Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 9.5.2.4. Argentina Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 9.5.3.2. Rest Of South America Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 9.5.3.3. Rest Of South America Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 9.5.3.4. Rest Of South America Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 10. Middle East and Africa Peptide Synthesis Market Size and Forecast By Segmentation (By Value USD Mn) (2023-2030) 10.1. Middle East and Africa Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 10.2. Middle East and Africa Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 10.3. Middle East and Africa Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 10.4. Middle East and Africa Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 10.5. Middle East and Africa Peptide Synthesis Market Size and Forecast, By Country (2023-2030) 10.5.1. South Africa 10.5.1.1. South Africa Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 10.5.1.2. South Africa Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 10.5.1.3. South Africa Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 10.5.1.4. South Africa Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 10.5.2. GCC 10.5.2.1. GCC Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 10.5.2.2. GCC Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 10.5.2.3. GCC Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 10.5.2.4. GCC Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 10.5.3. Rest Of MEA 10.5.3.1. Rest Of MEA Peptide Synthesis Market Size and Forecast, By Product(2023-2030) 10.5.3.2. Rest Of MEA Peptide Synthesis Market Size and Forecast, By Technology(2023-2030) 10.5.3.3. Rest Of MEA Peptide Synthesis Market Size and Forecast, By Application(2023-2030) 10.5.3.4. Rest Of MEA Peptide Synthesis Market Size and Forecast, By End User(2023-2030) 11. Company Profile: Key Players 11.1. Thermo Fisher Scientific 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis (Technological strengths and weaknesses) 11.1.5. Strategic Analysis (Recent strategic moves) 11.1.6. Recent Developments 11.2. Bachem Holdings 11.3. Merck KGgA 11.4. GenScript Biotech Corporation 11.5. Kaneka Corporation 11.6. Biotage AG 11.7. Syngen International Ltd 11.8. Mesa Laboratories 11.9. CEM Corporation 11.10. ProteoGenix 11.11. Bio-Synthesis 11.12. Purolite 11.13. ChemPep 11.14. AmbioPharm 11.15. CPC Scientific Inc. 11.16. Polypeptide 11.17. Lonza Group Ltd 11.18. USV Peptides 12. Key Findings 13. Analyst Recommendations 13.1. Attractive Opportunities for Players in the Peptide Synthesis Market 13.2. Future Outlooks 14. Peptide Synthesis Market: Research Methodology
  • INQUIRE BEFORE BUYING
MMRLogo
America's Fastest Growing Market Research Firm